6505--Ranolazine Sustained Action (SA) Tablets
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79725R0036
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Deb Fassl deborah.fassl@va.gov (708) 786-5894
- Nicholas McGregor nicholas.mcgregor@va.gov (708) 786-4934
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is seeking a supply source for Ranolazine Sustained Action (SA) Tablets, specifically 500mg and 1000mg tablets in 60-count bottles. The solicitation (No. 36E79725R0036) aims to establish a five-year contract with a base year and four one-year option periods to support VA, DoD, Indian Health Service, and Bureau of Prisons facilities through Pharmaceutical Prime Vendor programs. Offerors must submit prices for both line items across all contract years, including a mandatory 0.5% Cost Recovery Fee. The contract will be awarded using a lowest-price technically acceptable methodology, with key qualification requirements including a unique NDC number, FDA approval, and acceptable manufacturing facilities. The proposal submission deadline was originally May 6, 2025, but has been extended to May 15, 2025, at 2:30 PM Central Time through subsequent amendments.
The solicitation is not set aside for any specific business category, with the small business size standard set at 1,300 employees under NAICS code 325412. The estimated annual requirements are substantial, including 229,028 bottles of 500mg tablets and 95,925 bottles of 1000mg tablets. While specific contract value details are not explicitly stated, the volume and multi-year nature suggest a significant procurement opportunity for pharmaceutical manufacturers. The contract will be administered through the Department of Veterans Affairs National Acquisition Center, with performance likely distributed across multiple federal healthcare facilities nationwide. The pharmaceutical preparation manufacturing contract represents a critical supply chain initiative for providing sustained-action cardiovascular medication across various federal healthcare systems.
Notice text
3 versions
Update #3 · Latest ·
This amendment extends the due date and time for receipt of offers. See Amendment for details.
Update #2 ·
Due date and time for receipt of offers has been extended.
Update #1 ·
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0036 0002.docx | DOCX document | |
| 36E79725R0036 0001.docx | DOCX document | |
| 36E79725R0036.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Ranolazine SA Tablets - Radha - 11/20/25 - 11/19/26 | Award Notice | |
| This notice | Solicitation | |
| 6505--Ranolazine Sustained Action (SA) Tablets | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity